Trials / Withdrawn
WithdrawnNCT00249886
Discontinuation Study Of Citalopram (Antidepressant) in Depressed Adolescents
- Status
- Withdrawn
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 60 (planned)
- Sponsor
- Sunnybrook Health Sciences Centre · Academic / Other
- Sex
- All
- Age
- 13 Years – 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to evaluate whether it is advantageous for adolescents who have recovered from depression after a 6 to 12 week course of antidepressant treatment to stay on the treatment a further 6 months or is it just as helpful to stop the medication after recovery. The hypothesis is that adolescents with major depression who recover from the 6 to 12 week trial of citalopram will be less likely to have a recurrence of depression over a 6 month period if continued on the citalopram as compared to those who discontinue the medication.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Citalopram |
Timeline
- Start date
- 2002-09-01
- Completion
- 2006-11-01
- First posted
- 2005-11-07
- Last updated
- 2006-09-19
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT00249886. Inclusion in this directory is not an endorsement.